Adeptus Biotechnologies Corp. (ADPT) PT Raised to $21 at Guggenheim
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.77 +0.12%
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
13 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Guggenheim analyst Subbu Nambi raised the price target on Adeptus Biotechnologies Corp. (NASDAQ: ADPT) to $21.00 (from $20.00) while maintaining a Buy rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker
- argenx SE (ARGX) PT Raised to $1,353 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
